FBInvestor
Stocks / Moonlake Immunotherapeutics
Institutional Ownership

Moonlake Immunotherapeutics

CUSIP 61559X954PUTMLTXQ1 2026

No short-interest data on record yet

FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.